Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-23-008582
Filing Date
2023-06-16
Accepted
2023-06-16 16:25:00
Documents
1
Group Members
ALEXIS P. MICHASJOHN A. BARTHOLDSONJUNIPER HF INVESTORS II, LLCJUNIPER HF INVESTORS, LLCJUNIPER MULTI-STRATEGY FUND, L.P.JUNIPER TARGETED OPPORTUNITIES, L.P.JUNIPER TARGETED OPPORTUNITY FUND, L.P.JUNIPER TARGETED OPPORTUNITY INVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 z616230sc13da3.htm SC 13D/A 164643
  Complete submission text file 0001214659-23-008582.txt   166486
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Subject) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92368 | Film No.: 231021527
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 555 MADISON AVENUE 24TH FLOOR NEW YORK NY 10022-3315
Business Address 555 MADISON AVENUE 24TH FLOOR NEW YORK NY 10022-3315 (212) 339-8500
Juniper Investment Company, LLC (Filed by) CIK: 0001794034 (see all company filings)

EIN.: 263365915
Type: SC 13D/A